We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Screening Tool Simplifies Serological Diagnosis of Neurocysticercosis

By LabMedica International staff writers
Posted on 24 Jul 2014
Print article
Image: Taenia solium cysticerci, which represent the larval or intermediate, immature developmental stages of this pork tapeworm (Photo courtesy of Dr. George R. Healy).
Image: Taenia solium cysticerci, which represent the larval or intermediate, immature developmental stages of this pork tapeworm (Photo courtesy of Dr. George R. Healy).
The availability of a rapid serological diagnosis that targets stage-specific antibodies for human cysticercosis is considered very helpful in control programs for estimating the sero-prevalence or burden of the disease in susceptible population groups.

Cysticercosis is a tissue infection caused by hatched oncospheres, a larval form of the pork tapeworm Taenia solium which parasitize the intestinal wall and circulate through the bloodstream, invade the nervous system and form cysts in the brain, leading to neurocysticercosis.

Medical parasitologists at the Leiden University Medical Center (The Netherlands) and their American colleagues developed a field-friendly screening tool to simplify serological diagnosis of neurocysticercosis. A total of 63 banked serum samples from patients with confirmed neurocysticercosis were used to validate the assay, and a total of 170 serum samples collected in regions where transmission of cysticercosis does not occur, were used to assess specificity. These samples consisted of a panel of 78 serum samples assembled from healthy residents of the USA and a panel of 92 serum samples from blood bank donors in the Netherlands.

The assay utilizes novel nano-sized up-converting phosphor (UCP) reporter particles in combination with a portable lightweight analyzer and detects antibodies in serum samples reactive with bacterial-expressed recombinant (r) T24H, a marker for detecting neurocysticercosis cases. Three sequential flow steps allow enrichment of antibodies on the Test (T) line and consecutive binding of protein-A coated UCP reporter particles. Antibody binding was determined by measuring 550-nm emission after excitation of the UCP label with a 980 nm infrared (IR) diode. Lateral flow (LF) strips were scanned using a multistrip scanner, modified Packard Fluorocount microplate reader (PerkinElmer; Waltham, MA, USA) and a customized ESEQuant lateral flow reader (LFR) (QIAGEN Lake Constance; Stockach, Germany).

The clinical sensitivity and specificity of the assay to detect cases of human neurocysticercosis with two or more viable brain cysts were 96% and 98%, respectively, using a sample set comprised of sera from 63 confirmed cases and 170 healthy parasite-naïve non-endemic controls. The evaluation of the new test with a set of clinical samples indicated excellent clinical parameters comparable to an enzyme-linked immunosorbent assay (ELISA). Application of new nano-sized UCP reporter label and a lightweight strip analyzer, both from easily accessible sources, demonstrated equivalent performance compared to previous studies. The study was published on July 3, 2014, in the journal Public Library of Science Neglected Tropical Diseases.


Related Links:

Leiden University Medical Center
PerkinElmer
QIAGEN


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Specimen Collection & Transport
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.